Phase 2, single arm study of ticilimumab in patients with refractory metastatic adenocarcinoma of the colon or rectum
Phase of Trial: Phase II
Latest Information Update: 06 Jun 2012
At a glance
- Drugs Tremelimumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Sponsors Pfizer
- 31 Aug 2018 Biomarkers information updated
- 06 Jun 2012 Company (AstraZeneca) added as reported by ClinicalTrials.gov.
- 10 Jul 2008 Status changed from in progress to completed, from clinicaltrials.gov record.